Daisuke Tamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daisuke Tamura has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Hirokazu Yamagishi
Department of Pediatrics, Nasu Institute for Developmental Disabilities International University of Health and Welfare Otawara Japan
5 shared publications Takanori Yamagata
Department of Pediatrics, Jichi Medical University, Shimotsuke-shi, Japan
5 shared publicationsHitoshi Osaka
Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan
3 shared publications- Hitoshi Osaka
Jichi Medical University
3 shared publications - Shin Nunomiya
Department of Intensive Care, Yokosuka General Hospital Uwamachi, Kanagawa, Japan
3 shared publications - Takanori Yamagata
Department of Pediatrics, Jichi Medical University, Tochigi, Japan
3 shared publications
Latest Publications
- 1 June 2025
- Published by SAGE Publications in Viral Immunology
- Vol. 38 (5) , 172-179
Viral Titer of Respiratory Syncytial Virus in the Nasal Cavity in Different Sites in Children and Adults
Analysis of the viral load in respiratory syncytial virus (RSV) infection has focused on the nasopharyngeal site (NPS) near the lower respiratory tract, which is the primary lesion site, and the viral load in the anterior nasal site (ANS) near the nostrils has not been clarified in adults or children. The study evaluated the nasal distribution of RSV. A total of 49 patients, with 0 months to 71 years of age, participated in the study. A total of 774 specimens were collected from the ANS and NPS. In the pediatric group, the highest viral load in the NPS was 1.1 × 1010 copies/mL on day 1 of onset, and the highest in the ANS was 4.1 × 109 copies/mL on day 2. Thereafter, the viral load at both sites decreased gradually over time. The adult group showed a peak viral load on the onset day, with 1.5 × 1010 copies/mL in the NPS and 8.4 × 109 copies/mL in the ANS. By day 7 of onset, the viral load was 3.9 × 108 copies/mL in the NPS and 1.3 × 108 copies/mL in the ANS, indicating that the viral load at both sites remained parallel. We demonstrated that the RSV load was present in the ANS and NPS of children and adults from the date of onset. The ANS is closer to the nostrils and is a more promising specimen collection site than the NPS at all ages but has a lower viral load than the NPS.
- 1 June 2025
- Published by SAGE Publications in Viral Immunology
- Vol. 38 (5) , 172-179
Viral Titer of Respiratory Syncytial Virus in the Nasal Cavity in Different Sites in Children and Adults
Analysis of the viral load in respiratory syncytial virus (RSV) infection has focused on the nasopharyngeal site (NPS) near the lower respiratory tract, which is the primary lesion site, and the viral load in the anterior nasal site (ANS) near the nostrils has not been clarified in adults or children. The study evaluated the nasal distribution of RSV. A total of 49 patients, with 0 months to 71 years of age, participated in the study. A total of 774 specimens were collected from the ANS and NPS. In the pediatric group, the highest viral load in the NPS was 1.1 × 1010 copies/mL on day 1 of onset, and the highest in the ANS was 4.1 × 109 copies/mL on day 2. Thereafter, the viral load at both sites decreased gradually over time. The adult group showed a peak viral load on the onset day, with 1.5 × 1010 copies/mL in the NPS and 8.4 × 109 copies/mL in the ANS. By day 7 of onset, the viral load was 3.9 × 108 copies/mL in the NPS and 1.3 × 108 copies/mL in the ANS, indicating that the viral load at both sites remained parallel. We demonstrated that the RSV load was present in the ANS and NPS of children and adults from the date of onset. The ANS is closer to the nostrils and is a more promising specimen collection site than the NPS at all ages but has a lower viral load than the NPS.
- Open Access
- 4 April 2025
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (5) , 102692
Status of diagnostic test, diagnosis, and treatment of influenza using the national database of health insurance claims and specific health checkups of Japan
- 4 April 2025
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (5) , 102692
Open AccessStatus of diagnostic test, diagnosis, and treatment of influenza using the national database of health insurance claims and specific health checkups of Japan
- Open Access
- 2 May 2024
- Published by Taylor & Francis in Future Virology
- Vol. 19 (6-7) , 239-247
Remarkable proliferative ability of the Omicron variant in the nasal cavity compared to other SARS-CoV-2 variants
- 2 May 2024
- Published by Taylor & Francis in Future Virology
- Vol. 19 (6-7) , 239-247
Open AccessRemarkable proliferative ability of the Omicron variant in the nasal cavity compared to other SARS-CoV-2 variants
- Open Access
- 29 January 2024
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 6 (1) , 69-73
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Kinetics in Natural Infection: A Case Study
Background Omicron has become the mainstream epidemic variant of severe acute respiratory syndrome coronavirus 2 worldwide. One reason for the high infectivity of this variant is its ability to multiply rapidly in the human body. It has been speculated that, in general, the short period required for virus multiplication affects the incubation period and timing of viral shedding that begins during the incubation period. However, it is unclear whether these effects can be related to the Omicron variant. Similar to a recent human challenge study, in this study, patients with known timing of Omicron infection were followed up in a hospital before the onset of the disease. Methods In two patients, the viral shedding was investigated and analysed along with symptoms before and after the disease onset. Results The incubation period for Omicron was 30-36 h; this was shorter than the average incubation period of the alpha variant in the human challenge study and that reported in a systematic review and meta-analysis (3.5 days). Viral shedding at the nasal site began 19-22 h after infection, approximately 10 h before symptom onset. Conclusion The results of this study demonstrated that in some instances with Omicron (BA.5), the time to viral shedding and the time to disease onset were considerably shorter after infection than those previously reported for Omicron and Alpha variants. We showed the importance of early detection of the viral antigen after viral exposure and early isolation initiation to prevent infection spread.
- 29 January 2024
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 6 (1) , 69-73
Open AccessSevere Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Kinetics in Natural Infection: A Case Study
Background Omicron has become the mainstream epidemic variant of severe acute respiratory syndrome coronavirus 2 worldwide. One reason for the high infectivity of this variant is its ability to multiply rapidly in the human body. It has been speculated that, in general, the short period required for virus multiplication affects the incubation period and timing of viral shedding that begins during the incubation period. However, it is unclear whether these effects can be related to the Omicron variant. Similar to a recent human challenge study, in this study, patients with known timing of Omicron infection were followed up in a hospital before the onset of the disease. Methods In two patients, the viral shedding was investigated and analysed along with symptoms before and after the disease onset. Results The incubation period for Omicron was 30-36 h; this was shorter than the average incubation period of the alpha variant in the human challenge study and that reported in a systematic review and meta-analysis (3.5 days). Viral shedding at the nasal site began 19-22 h after infection, approximately 10 h before symptom onset. Conclusion The results of this study demonstrated that in some instances with Omicron (BA.5), the time to viral shedding and the time to disease onset were considerably shorter after infection than those previously reported for Omicron and Alpha variants. We showed the importance of early detection of the viral antigen after viral exposure and early isolation initiation to prevent infection spread.
- 12 January 2024
- Published by Wiley in Pediatrics International
- Vol. 66 (1) , e15717
Severe hemolytic anemia in a glucose‐6‐phosphate dehydrogenase‐deficient child with COVID ‐19
- 12 January 2024
- Published by Wiley in Pediatrics International
- Vol. 66 (1) , e15717
Severe hemolytic anemia in a glucose‐6‐phosphate dehydrogenase‐deficient child with COVID ‐19
- Open Access
- 4 January 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (1) , 119
Temporal Trend of the SARS-CoV-2 Omicron Variant and RSV in the Nasal Cavity and Accuracy of the Newly Developed Antigen-Detecting Rapid Diagnostic Test
The aim of this work is to analyze the viral titers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and respiratory syncytial virus (RSV) at the anterior nasal site (ANS) and nasopharyngeal site (NS), evaluate their virological dynamics, and validate the usefulness of a newly developed two-antigen-detecting rapid antigen diagnostic test (Ag-RDT) that simultaneously detects SARS-CoV-2 and RSV using clinical specimens. This study included 195 asymptomatic to severely ill patients. Overall, 668 specimens were collected simultaneously from the ANS and NS. The cycle threshold (Ct) values calculated from real-time polymerase chain reaction were used to analyze temporal changes in viral load and evaluate the sensitivity and specificity of the Ag-RDT. The mean Ct values for SARS-CoV-2-positive, ANS, and NS specimens were 28.8, 28.9, and 28.7, respectively. The mean Ct values for RSV-positive, ANS, and NS specimens were 28.7, 28.8, and 28.6, respectively. SARS-CoV-2 and RSV showed the same trend in viral load, although the viral load of NS was higher than that of ANS. The sensitivity and specificity of the newly developed Ag-RDT were excellent in specimens collected up to 10 days after the onset of SARS-CoV-2 infection and up to 6 days after the onset of RSV infection.
- 4 January 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (1) , 119
Open AccessTemporal Trend of the SARS-CoV-2 Omicron Variant and RSV in the Nasal Cavity and Accuracy of the Newly Developed Antigen-Detecting Rapid Diagnostic Test
The aim of this work is to analyze the viral titers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and respiratory syncytial virus (RSV) at the anterior nasal site (ANS) and nasopharyngeal site (NS), evaluate their virological dynamics, and validate the usefulness of a newly developed two-antigen-detecting rapid antigen diagnostic test (Ag-RDT) that simultaneously detects SARS-CoV-2 and RSV using clinical specimens. This study included 195 asymptomatic to severely ill patients. Overall, 668 specimens were collected simultaneously from the ANS and NS. The cycle threshold (Ct) values calculated from real-time polymerase chain reaction were used to analyze temporal changes in viral load and evaluate the sensitivity and specificity of the Ag-RDT. The mean Ct values for SARS-CoV-2-positive, ANS, and NS specimens were 28.8, 28.9, and 28.7, respectively. The mean Ct values for RSV-positive, ANS, and NS specimens were 28.7, 28.8, and 28.6, respectively. SARS-CoV-2 and RSV showed the same trend in viral load, although the viral load of NS was higher than that of ANS. The sensitivity and specificity of the newly developed Ag-RDT were excellent in specimens collected up to 10 days after the onset of SARS-CoV-2 infection and up to 6 days after the onset of RSV infection.
- Open Access
- 6 December 2023
- Published by MDPI AG in Preprints.org
Temporal Trend of the SARS-CoV-2 Omicron Variant and Res-Piratory Syncytial Virus in the Nasal Cavity and Accuracy of the Newly Developed Antigen-Detecting Rapid Diagnostic Test
To analyze the viral titers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and respiratory syncytial virus (RSV) at the anterior nasal site (ANS) and nasopharyngeal site (NS), evaluate their virological dynamics, and validate the usefulness of a newly developed two antigen-detecting rapid antigen diagnostic test (Ag-RDT) that simultaneously detects SARS-CoV-2 and RSV using clinical specimens. This study included 195 asymptomatic to severely ill patients. Overall, 668 specimens were collected simultaneously from the ANS and NS. The cycle threshold (Ct) values calculated from real-time polymerase chain reaction were used to analyze temporal changes in viral load and evaluate the sensitivity and specificity of the Ag-RDT. The mean Ct values for SARS-CoV-2-positive, ANS, and NS specimens were 28.8, 28.9, and 28.7, respectively. The mean Ct values for RSV-positive, ANS, and NS specimens were 28.7, 28.8, and 28.6, respectively. SARS-CoV-2 and RSV showed the same trend in viral load, although the viral load of NS was higher than that of ANS. The sensitivity and specificity of the newly developed Ag-RDT were excellent in specimens collected up to 10 days after the onset of SARS-CoV-2 infection and up to 6 days after the onset of RSV infection.
- 6 December 2023
- Published by MDPI AG in Preprints.org
Open AccessTemporal Trend of the SARS-CoV-2 Omicron Variant and Res-Piratory Syncytial Virus in the Nasal Cavity and Accuracy of the Newly Developed Antigen-Detecting Rapid Diagnostic Test
To analyze the viral titers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and respiratory syncytial virus (RSV) at the anterior nasal site (ANS) and nasopharyngeal site (NS), evaluate their virological dynamics, and validate the usefulness of a newly developed two antigen-detecting rapid antigen diagnostic test (Ag-RDT) that simultaneously detects SARS-CoV-2 and RSV using clinical specimens. This study included 195 asymptomatic to severely ill patients. Overall, 668 specimens were collected simultaneously from the ANS and NS. The cycle threshold (Ct) values calculated from real-time polymerase chain reaction were used to analyze temporal changes in viral load and evaluate the sensitivity and specificity of the Ag-RDT. The mean Ct values for SARS-CoV-2-positive, ANS, and NS specimens were 28.8, 28.9, and 28.7, respectively. The mean Ct values for RSV-positive, ANS, and NS specimens were 28.7, 28.8, and 28.6, respectively. SARS-CoV-2 and RSV showed the same trend in viral load, although the viral load of NS was higher than that of ANS. The sensitivity and specificity of the newly developed Ag-RDT were excellent in specimens collected up to 10 days after the onset of SARS-CoV-2 infection and up to 6 days after the onset of RSV infection.
- Open Access
- 11 July 2023
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 11, 1201825
Impact of the omicron phase on a highly advanced medical facility in Japan
Background: Eight waves of the coronavirus disease 2019 (COVID-19) epidemic have been observed in Japan. This retrospective study was conducted to clarify the clinical characteristics of pediatric COVID-19 patients.Methods: We studied 121 patients admitted to the Jichi Children's Medical Center Tochigi between April 2020 and March 2023. Incidence of pediatric COVID-19 in Tochigi Prefecture was used to examine hospitalization and severe illness rates.Results: The mean age of the patients was 3 years and 8 months. One hundred and eleven patients (91.7%) were hospitalized after January 2022 (after the 6th wave), when the Omicron strain became endemic in Japan. Convulsions occurred in 30 patients (24.8%), all of whom were admitted after the 6th wave. Twenty-three of the 30 patients had no underlying disease. Eleven patients (9.1%) were diagnosed with acute encephalopathy. One patient died due to hemorrhagic shock and encephalopathy syndrome and two had sequelae after the 6th wave. The patient who died due to encephalopathy had hypercytokinemia. In the Tochigi Prefecture, the number of pediatric COVID-19 patients increased after the 6th wave, but the hospitalization rate declined. The rate of severe illness did not change before the end of 5th and after the 6th wave.Conclusion: Although the rate of severe illness in patients with pediatric COVID-19 did not increase after the 6th wave, some patients had complicated critical illnesses. Systemic inflammatory reaction was considered to have been associated with the severe encephalopathy.
- 11 July 2023
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 11, 1201825
Open AccessImpact of the omicron phase on a highly advanced medical facility in Japan
Background: Eight waves of the coronavirus disease 2019 (COVID-19) epidemic have been observed in Japan. This retrospective study was conducted to clarify the clinical characteristics of pediatric COVID-19 patients.Methods: We studied 121 patients admitted to the Jichi Children's Medical Center Tochigi between April 2020 and March 2023. Incidence of pediatric COVID-19 in Tochigi Prefecture was used to examine hospitalization and severe illness rates.Results: The mean age of the patients was 3 years and 8 months. One hundred and eleven patients (91.7%) were hospitalized after January 2022 (after the 6th wave), when the Omicron strain became endemic in Japan. Convulsions occurred in 30 patients (24.8%), all of whom were admitted after the 6th wave. Twenty-three of the 30 patients had no underlying disease. Eleven patients (9.1%) were diagnosed with acute encephalopathy. One patient died due to hemorrhagic shock and encephalopathy syndrome and two had sequelae after the 6th wave. The patient who died due to encephalopathy had hypercytokinemia. In the Tochigi Prefecture, the number of pediatric COVID-19 patients increased after the 6th wave, but the hospitalization rate declined. The rate of severe illness did not change before the end of 5th and after the 6th wave.Conclusion: Although the rate of severe illness in patients with pediatric COVID-19 did not increase after the 6th wave, some patients had complicated critical illnesses. Systemic inflammatory reaction was considered to have been associated with the severe encephalopathy.
- 7 March 2023
- Published by Elsevier in Journal of Infection
- Vol. 86 (6) , 584-587
Omicron proliferation in the nasal cavity may explain its high infectivity
- 7 March 2023
- Published by Elsevier in Journal of Infection
- Vol. 86 (6) , 584-587
Omicron proliferation in the nasal cavity may explain its high infectivity
- Open Access
- 17 September 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 124, 199-205
Diagnostic accuracy of a novel SARS CoV-2 rapid antigen test and usefulness of specimens collected from the anterior nasal cavity
- 17 September 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 124, 199-205
Open AccessDiagnostic accuracy of a novel SARS CoV-2 rapid antigen test and usefulness of specimens collected from the anterior nasal cavity